NAD sheds weight claims, adds to FTC’s load
This article was originally published in The Tan Sheet
Executive Summary
Print and broadcast advertising for Carter-Reed's Relacore has been referred to the Federal Trade Commission after the firm's "failure to provide a substantive response" to NAD's inquiry, the watchdog group states in an upcoming Case Reports. The Council of Better Business Bureaus division came across the claims "A natural feel-good pill called Relacore might be the perfect answer to belly fat" and "The most significant weight-control advancement in more than a decade" during a routine review. Carter-Reed said "it had prepared a confidential submission for NAD," but never submitted the statement...